Company: ISRG
Filing Date: 2025-07-23
Form Type: 10-Q
Source: 0001035267-25-000192
Chunk: 24

Company: INTUITIVE SURGICAL INC
Filing Date: 2025-07-23
Form: 10-Q
Item: Item 1
Chunk 24
---
3 54.3 0.4 54.7 Net income attributable to noncontrolling interest in joint venture— — — — — — 11.1 11.1 Ending balance358.4 $0.4 $10,236.8 $7,605.5 $3.0 $17,845.7 $107.4 $17,953.1 Six Months Ended June 30, 2024Common StockAdditional Paid-In CapitalRetained EarningsAccumulated Other Comprehensive Income (Loss)Total Intuitive Surgical, Inc. Stockholders’ EquityNoncontrolling Interest in Joint VentureTotal Stockholders’ EquitySharesAmountBeginning balance352.3 $0.4 $8,576.4 $4,743.0 $(12.2)$13,307.6 $89.7 $13,397.3 Issuance of common stock through employee stock plans3.6 — 251.9 — — 251.9 — 251.9 Shares withheld related to net share settlement of equity awards(0.6)— (7.0)(233.1)— (240.1)— (240.1)Share-based compensation expense related to employee stock plans— — 328.4 — — 328.4 — 328.4 Net income attributable to Intuitive Surgical, Inc.— — — 1,071.8 — 1,071.8 — 1,071.8 Other comprehensive income (loss)— — — — (11.3)(11.3)(0.6)(11.9)Cash dividends declared and paid by joint venture— — — — — — (8.0)(8.0)Net income attributable to noncontrolling interest in joint venture— — — — — — 7.1 7.1 Ending balance355.3 $0.4 $9,149.7 $5,581.7 $(23.5)$14,708.3 $88.2 $14,796.5 

Stock Repurchase ProgramThe Company’s Board of Directors (the “Board”) has authorized an aggregate of $13.0 billion of funding for the Company’s common stock repurchase program (